drugset / Trial / NCT04272086
Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study team will be randomizing patients presenting for open myomectomy to either received transversus abdominal plane blocks with either liposomal bupivacaine or standard bupivacaine. The study team will be analyzing the impact of local anesthetic on opiate consumption as the investigator's primary endpoint with other secondary endpoints.
Timeline
- Start
- 2020-11-09
- Primary completion
- 2025-10-28
- Completion
- 2025-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Subject | Bupivacaine | Other / unclassified | 10 ml | Other |